BociMed

About:

BociMed is a company engaged in drug research and development and clinical research.

Website: http://abc.bocimed.com

Top Investors: Shanghai STVC Group, Guoxin Investment, Richen Capital, Spinnotec, Zhangjiang Torch Venture Capital Co

Description:

BociMed is a company engaged in drug research and development and clinical research. Through the establishment of a standardized service system, it provides high-quality R&D and outsourcing services for drug discovery, preclinical pharmaceutical research and development, clinical I-IV trials and registration.Shanghai Bozhiyan New Drug Technology Co., Ltd. is a high-tech enterprise specializing in drug research and development technical services, Shanghai High-tech Enterprise, Shanghai Credit Creation Enterprise, and Shanghai Small and Medium Enterprise Innovation Undertaking Enterprise. The company started in 2007 and was formerly known as Shanghai Maibo Pharmaceutical Technology Co., Ltd., registered in Jinshan Petrochemical Zone, mainly engaged in raw material sales, drug import registration and regional cooperation development in China. In 2012,

Total Funding Amount:

100M CNY

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2012-01-01

Contact Email:

hr-recruiting(AT)bocimed.com

Founders:

Number of Employees:

251-500

Last Funding Date:

2023-02-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai